Scientists from a multinational collaboration involving institutions in the United States, Germany, and Singapore have introduced a transformative 3D color imaging technique capable of visualizing blood flow through human tissues in vivid, intuitive detail. The innovation, detailed in a January 23, 2026 publication in Nature Photonics, builds on optical coherence tomography (OCT) by integrating multispectral illumination and advanced computational algorithms to simultaneously capture structural anatomy and dynamic blood flow information.

Traditional OCT excels at high resolution cross sectional imaging of tissue layers but struggles to convey flow dynamics in an easily interpretable way. Doppler OCT variants can measure velocity but often produce noisy or monochromatic maps that are difficult for clinicians to read quickly. The new ColorFlow OCT technique overcomes these limitations by using carefully tuned wavelengths of light to probe moving red blood cells, then applying machine learning based reconstruction to assign biologically meaningful colors: red for fast moving arterial flow, blue for slower venous return, and gradient hues for intermediate velocities and capillary networks.

In first in human demonstrations, the system produced stunning 3D color rendered volumes of blood flow in the retina, skin, and brain (via intraoperative use). The technique revealed microvascular patterns invisible to the naked eye or conventional imaging such as early perfusion deficits in diabetic retinopathy, abnormal vascular remodelling in skin lesions, and subtle flow alterations in brain tissue adjacent to tumors. Acquisition time per volume was under 5 seconds, fast enough for real time intraoperative guidance or bedside monitoring.

The non-invasive, radiation free nature of the method makes it ideal for repeated assessments, while its portability (using compact fibre optic probes) supports use in outpatient clinics, ICUs, and resource-limited settings. Early validation showed excellent correlation with gold standard techniques like fluorescein angiography and laser Doppler perfusion imaging, but with superior spatial resolution and 3D context.

Dr. Elena Martinez, lead author from the collaborating team, highlighted the clinical significance: “Blood flow tells us whether tissue is healthy, ischemic, or inflamed long before structural damage becomes obvious. By turning complex flow data into intuitive 3D color maps, we give clinicians a tool that is both scientifically powerful and immediately understandable something that can change decisions at the bedside or in the operating room.”

The technology has already attracted interest from medical device manufacturers for integration into commercial OCT systems, with potential applications extending beyond diagnostics to intraoperative navigation, wound healing assessment, and monitoring of vascular therapies. The research team is now pursuing larger multi centre trials to establish reference ranges across age groups, skin types, and disease states.

This advancement underscores the growing convergence of optical imaging, artificial intelligence, and computational modelling in modern medicine offering a window into microvascular health that was previously inaccessible outside specialised research labs.